Session Type
Meeting
Search Results for VTE
Abstract Number: 215
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: It is widely accepted that hospitalized patients warrant risk assessment for venous thromboembolism (VTE) upon hospital admission. Although many VTE risk assessment models include a patient mobility element for calculating risk, a standardized method of determining mobility is lacking. We sought to determine if physician assessment of anticipated patient mobility upon hospital admission using […]
Abstract Number: 235
SHM Converge 2024
Background: Venous thromboembolism (VTE) is a leading cause of preventable in-hospital mortality and a primary focus of quality improvement/patient safety efforts. VTE prophylaxis reduces the incidence of in-hospital VTE, but nonadministration rates—primarily attributed to patient refusal—often reach 10-15%. Notably, nonadministration of VTE prophylaxis may correlate with higher incidence of hospital acquired VTE. Prior studies showed […]
Abstract Number: 245
SHM Converge 2024
Background: Venous thromboembolism (VTE) is a prevalent and costly medical condition in hospitalized patients. Risk assessment tools like the Padua Predictive Score aim to differentiate low-risk and high-risk patients for targeted pharmaceutical prophylaxis (pPPX) administration. However, widespread adoption of risk assessment remains suboptimal. This study investigates HA VTE prophylaxis use in medicine inpatients within a […]
Abstract Number: 247
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Venous thromboembolism (VTE) is a preventable and potentially fatal condition for which hospitalized medical patients are at risk. Compared with the more traditional option of unfractionated heparin, low molecular weight heparin (LMWH) has been shown to be superior for VTE prophylaxis with regard to both efficacy and bleeding risk, and to have a lower […]
Abstract Number: 283
Hospital Medicine 2020, Virtual Competition
Background: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), constitute a major health problem in the United States Health System, with a reported high mortality rate and significant economic toll. Despite the prevalence of VTE and associated mortality, clinicians have struggled in prescribing appropriate VTE prophylaxis for the inpatient population, often […]
Abstract Number: 296
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Despite strong performance on Venous Thromboembolism (VTE) Core Measures, our institutional approach to VTE prophylaxis placed significant burden on providers through frequent automated alerts. Within our Electronic Medical Record (EMR), provider alerts triggered when a patient with at least one identified risk factor for VTE did not have prophylactic medication ordered. However, only 11% […]
Abstract Number: 306
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), affects one to two per one thousand persons annually in the US. Treatment of VTE consists of anticoagulation therapy, and evidence supports treating patients with low-risk VTEs as outpatients. Novel oral agents such as rivaroxaban, an oral factor Xa inhibitor, require less […]
Abstract Number: 330
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Risk factors for hospital-acquired venous thromboembolism (HA-VTE) have been well-studied in adults, with validated risk assessment tools available. Adults admitted to children’s hospitals are younger but with comorbidities stemming from childhood conditions. There is a paucity of data on HA-VTE characteristics and risk factors in this population. Our objective was to evaluate HA-VTE in […]
Abstract Number: 359
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Updated guidelines recommend testing for inherited or acquired thrombophilias only in rare situations in the acute inpatient care setting, as it has little impact on acute management of thromboembolic events, and in some situations, can be falsely positive leading to inappropriate care. Current data in our academic medical center indicate testing for thrombophilia occurs […]
Abstract Number: 421
Hospital Medicine 2020, Virtual Competition
Background: VTE is associated with considerable morbidity and mortality, in fact, as many as 10% of deaths of hospitalized patients have been contributed to pulmonary embolism.1 The ACP and AACP in their 2011 and 2012 guidelines, respectively, recommend that all hospitalized patients be evaluated for risk of VTE, and subsequent prophylaxis be initiated if benefits […]